Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:HGEN

Humanigen (HGEN) Stock Price, News & Analysis

Humanigen logo

About Humanigen Stock (NASDAQ:HGEN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2.06 million shs
Average Volume
3.26 million shs
Market Capitalization
$24 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humanigen and its competitors with MarketBeat's FREE daily newsletter.

HGEN Stock News Headlines

Post-Halving = Profit Season (Here’s How to Win It)
It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how to trade it, this phase brings the most potential. We’re now in that window. A free workshop outlines how a proven system is targeting daily wins, passive income, and explosive upside through curated altcoin picks. Whether you're new to crypto or looking to catch the next move with confidence, this is your roadmap. And just for showing up, you’ll receive $10 in real Bitcoin. Don’t miss it.
Humanigen, Inc. (HGEN)
0KB1.SG,0P00011RKD,0 (0KB1.SG)
Humanigen Inc (0KB2.BE)
Humanigen Inc HGENQ
See More Headlines

HGEN Stock Analysis - Frequently Asked Questions

Humanigen, Inc. (NASDAQ:HGEN) announced its earnings results on Friday, November, 12th. The company reported ($1.12) EPS for the quarter, missing analysts' consensus estimates of ($0.98) by $0.14. The firm had revenue of $1.04 million for the quarter, compared to analyst estimates of $0.40 million.

Humanigen's stock reverse split on Monday, September 14th 2020.The 1-5 reverse split was announced on Friday, September 4th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, September 11th 2020. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Humanigen investors own include NVIDIA (NVDA), Tesla (TSLA), Meta Platforms (META), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Pfizer (PFE) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/12/2021
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:HGEN
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.70 million
Price / Cash Flow
N/A
Book Value
($0.45) per share
Price / Book
N/A

Miscellaneous

Free Float
93,240,000
Market Cap
$24 thousand
Optionable
No Data
Beta
-1.04
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:HGEN) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners